Regenerx Biopharmaceuticals Inc
RGRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000707511
Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 1
- Q3 2023, 0 vs. previous quarter
- 13F value
- $170
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding RGRX, Q3 2023
No superinvestor reported holding RGRX at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by Regenerx Biopharmaceuticals Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2023 (view filing)4:30 PM ET | Jul 3 | 3 days | Essetifin SPA and 6 others10% Owner | PPurchaseConvertible Promissory Note (right to buy) | – | – | – | – | DerivativePrice outlier |
| Jul 6, 2021 (view filing)4:35 PM ET | Jun 30 | 6 daysLate | Finkelstein J JPresident and CEO | PPurchase | +75.0K | $0.20 | +$15.0K | +4.6%1.71M after | |
| Jul 6, 2021 (view filing)4:35 PM ET | Jun 30 | 6 daysLate | Finkelstein J JPresident and CEO | PPurchase | +112.5K | $0.00 | $0 | –56.3K after | Derivative2 lots |
| Jul 6, 2021 (view filing)4:34 PM ET | Jun 30 | 6 daysLate | Goldstein Allan LDirector | PPurchase | +125.0K | $0.20 | +$25.0K | +8.3%1.64M after | |
| Jul 6, 2021 (view filing)4:34 PM ET | Jun 30 | 6 daysLate | Goldstein Allan LDirector | PPurchase | +187.5K | $0.00 | $0 | –93.8K after | Derivative2 lots |
| Jul 2, 2021 (view filing)4:16 PM ET | Jun 30 | 2 days | Cavazza Paolo10% Owner | PPurchase | +1.50M | $0.20 | +$300.0K | New position1.50M after |
Top 10 13F holders, Q3 2023
The largest institutional positions in Regenerx Biopharmaceuticals Inc at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Williams Jones Wealth Management, LLC. | 10,000 | $170 | 0.00% | 00.0% | Unchanged |